KRAS G12C inhibitor 13 Catalog No.:M24067-C and potently and selectively inhibits

and potently and selectively inhibits the growth of MCF-7 breast cancer cells with a GI50 of 0

29)30)36-8-11(7-32-36)10-2-3-13(22)12(6-10)16(37)33-18(9-31)4-5-18/h2-3

caspase-3 and caspase-9 cleavage occurrs continuously over 72 hours

carnitine palmitoyltransferase 1a (Cpt1a) and hydroxyacyl-CoA dehydrogenase (Hadha)

KRAS G12C inhibitor 13 Catalog No.:M24067-C and potently and selectively inhibitsKRAS G12C inhibitor 13 is a KRAS G12C inhibitor extracted from patent WO2018143315A1, compound 30. Product information CAS Number: 2241719 75 3 Molecular Weight: 745. 83 Formula: C40H46F3N7O4 Chemical Name: 1 {7 [6 ethenyl 7 (5 methyl 1H indazol 4 yl) 2 {[1 (oxan 4 yl)piperidin 4 yl]oxy} 8 (2,2,2 trifluoroethoxy)quinazolin 4 yl] 2,7 diazaspiro[3. 5]nonan 2 yl}prop 2 en 1 one Smiles: